|
|||||||||||||||||||||||||||||||||||||||||||||||
| probe | Examination | Frequency | depth of measurements | thoracic perimeter * |
|
S |
Small 1 (S1) |
5 MHz |
De 15 mm à 40 mm |
≤ 45 cm |
|
|
Small 2 (S2) |
5 MHz |
De 20 mm à 50 mm |
> 45 cm et ≤ 75 cm |
(*) at the xyphoid process
1 inch = 2,54 cm
Availability
EC +, the S probe will be commercially available in Europe from January 2008.
PAEDIATRIC
A revolution in the field of paediatrics
“With the S probe, we are offering a technology concentrate for the benefit of children.” Bertrand Fourquet, President of ECHOSENS.
The S probe was created to respond to the growing number of children suffering from chronic liver diseases. It will give the physician a better chance to make a diagnosis and an early follow-up of the disease.
Because there are more than 100 diverse and varied liver pathologies which affect children throughout the world. In the ranks of the most important are mucoviscidosis, bile duct diseases and the danger of the future: Nash.
The S probe, an innovative accessory, is a made-to-order response to the specific diagnostic needs of children from 1 month to 14 years of age.
On account of the specific morphology of the child (more reduced intercostal space, small size liver) our teams of experts have developed an effective solution (reduced transducer size, algorithm adapted to measure a liver of small size, etc.).
Key factors of success
| features | the impact on your diagnosis |
|
Opuimised ergonomics |
Easier handling |
|
Light shell |
Greater operator comfort |
|
A thinner transducer |
Passes between the ribs of a child |
|
Adapted algorithm |
Effectivily measure a small size liver |
Assets of the FibroScan® examination
in the child, compared to biopsy
| Restrictive examination | Biopsy | FibroScan® S probe exam |
|
Anesthesia |
Yes (general) |
No |
|
Hospitalization |
Yes (48 hours) |
No |
|
Preliminary examination |
Yes (hepatic echography and a blood coagulation study) |
No |
| Harmful examination | Biopsy | FibroScan® S probe exam |
|
Complications disagreeable but not severe |
Pain or haematoma at the point of needle entry |
No |
|
Serious complication, wich may, if untreated, be lifethreatening |
Concerns less than one case of one thousand biopsies :
|
No |
Abstract et oral presentation at AASLD 2007
A dedicated FibroScan® probe to evaluated liver fibrosis in children : feasibility and performance for the diagnosis of cirrhosis. V. de Ledinghen et al.




